Focused on the research and development and production of resin materials and resin end products - Hebei Lijiang
-
AboutHebei Lijiang Biotechnology Co., Ltd. is a new material manufacturer specializing in the production of functional special ion exchange resins and disposable blood perfusion devices. It is a modern high-tech enterprise integrating the research and development, production, sales, and service of resin materials and resin end products. The company was established in April 2014 with a registered capital of 52 million yuan. It plans to cover an area of 267 acres and is located in the High-tech Industrial Park of Weixian County, Hebei Province—New Material Demonstration Park. The total investment is 510 million yuan. It is a council member unit of the Ion Exchange Resin Branch of the China Membrane Industry Association.
-
Product
-
BlogsThe company will focus on the high-end market, with the purpose of serving society, solidly carrying out technological innovation and product promotion, continuously improving the development and expansion of ion exchange resin products in emerging application fields, thereby promoting the upgrading and development of related industries.
-
Company AlbumThe current phase of construction has been fully completed and put into operation, featuring a comprehensive workshop with 42 production lines for functional ion exchange resins with an annual output of 16,800 tons and a production capacity of 30,000 tons, a wastewater treatment plant with an annual treatment capacity of 403,000 tons, and a workshop producing 5,000 tons of medical-grade magnesium sulfate annually. Trial production began in July 2016, with official production starting in January 2017.
Professor Feng Yaqing from Tianjin University visited our company for inspection and guidance
Release Time:
2020-07-25
To deepen the cooperation between industry, academia, and research, and to fully leverage the advantages of both the school and enterprises, 2020 Year 7 Month 24 On [Year] [Month] [Day], Professor Feng Yaqing, former Vice President of Tianjin University, Party Secretary of the School of Chemical Engineering, and doctoral supervisor, visited our company for inspection and guidance. Chairman Mao Jiang and other key personnel participated in the reception.
In recent years, the School of Chemical Engineering at Tianjin University has undertaken multiple national and provincial-level educational reform projects, achieving fruitful results. In the field of basic research, synthetic biology has made significant breakthroughs, establishing China's international status in the chemical synthesis of the human genome. Several achievements such as large-scale packed tower separation technology, pharmaceutical crystallization technology, bioprocessing technology, and new catalysts and reaction technologies have reached internationally advanced levels, exerting significant influence in related industries and generating substantial economic benefits.
In recent years, our company has continuously deepened industry-academia-research cooperation with higher education institutions, accelerated technological innovation research on polymer ion exchange resins, and built provincial-level R&D platforms. We have undertaken two national scientific research projects and multiple local research projects, achieving a series of important accomplishments that have supported rapid enterprise development and played a significant role in advancing industry technology.
During this visit, Professor Feng fully affirmed our company's efforts in scientific research and innovation, highly praised the achievements in building our research platform, and provided guiding opinions on our industry-academia-research cooperation. Chairman Mao expressed the commitment to continuously enhance the company's innovation capabilities, carry out multi-level, multi-form, and multi-field cooperation between industry, academia, and research, achieve organic integration and optimized allocation of school-enterprise resources, and jointly promote social progress and development.
Keyword:
Recommended Reading
24-05-14 14:37:56
